Treatment of differentiated carcinoma of thyroid gland with surgery and adjuvante Radioiodine- 131

Authors

  • José Ulisses Manzzini Calegaro Cancerologista e especialista em Medicina Nuclear. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Nely Queiroz Manzzini Calegaro Endocrinologista. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Lidia Vânia Duarte Endocrinologista. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Márcia Roberta Acioly Araujo Endocrinologista. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Márcia Dalla Miziara Endocrinologista. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Ênio de Freitas Gomes Especialista em Medicina Nuclear. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Luis Augusto Casulari R. da Motta Endocrinologista. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil
  • Marluce Alves de Andrade Técnica em Radioisótopos. Fundação Hospitalar do Distrito Federal, Brasília (DF), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.1996v42n4.2901

Keywords:

Differentiated Thyroid Carcinoma, Thyroidectomy, Adjuvant Radioiodine- 131 Treatment

Abstract

Aim: To analyse the results of differentiated thyroid cancer treatment by surgery and adjunctive radioiodine- 131. Material and methods: We analysed retrospectively 96 patients, from 1978 to 1993, with median age of 4l. 7 ± 15.0 years old (SD = 1), inciuding 86fema1es and with median time follow-up of 5.3 ± 4.0 years (SD = 1); they corresponded to 50 cases of papillary carcinoma (PC), 40 cases of follicular carcinoma (FC) and six cases of Hurthle cells (HC). These cases were divided in two groups: A. 81 cases (47PC, 28FC and 6HC) treated by thyroidectomy and complemental radioiodine; B. 15 cases (3PC and I2FC) treated by thyroidectomy and radíoiodine to metastases, the study groups were analysed by age: less than 50 years old (72 cases) and more than 50 years old (24 cases), survival time and associated diseases. Results: Group A showed one death (1.21%) and three cases (3.65%) of metastases in progression, Group B, five deaths (33.33%) andfive (33.33%) of metastases in progression. In patients less than 50 years old, mortality was 4.16% and metastases in progression = 5.55%; above 50 years old, the proportion were 12.5% and 16.66% respectively. All deaths and majority of distant metastases in progression occurred within 10 years of treatment. Nodular autonomous goitre was associated in seven cases (7.29%). General mortality and metastases in progression rates were 6.25% and 8.33% respectively, with all deaths and the most of distant metastases in progression being due to follicular carcinoma. Conclusions: 1. Total thyroidectomy and ablation of residual thyroid tissue with radioiodine may yeald the best results and be more safe. 2. Above 50 years of age the tumor has more aggressive evolution. 3. The highest incidence of mortality and distant progressive disease occurred within 10 years of treatment. 4. Follicular carcinoma must considered as prognostic factor of risk. 5. The association with nodular autonomous goitre is more common than usually thought considered.

Downloads

Download data is not yet available.

References

Samaan, N.A.; Shultz, P.N.; Hickey, R.C.; Goefert, H.; Hayne, T.P. et al. - The results of various modalities of treatment of well differentiated carcinomas: A retrospective review of 1959 patients. J Clin Endocrinol Metab, 75. 714-720, 1992. DOI: https://doi.org/10.1210/jc.75.3.714

Becker, D.V. - Radioactive iodine (1-13 1) in the treatment of hyperthyroidism. In: Beckers C. editor. Thyroid diseases. Paris: Pergamon Press, 145-158, 1982.

Tubiana, M. - Thyroid Cancer. In: Beckers, C. editor. Thyroid diseases. Pergamon Press, 187-227, 1982.

Cady, B. - Neoplasms of the thyroid. In: Holland, J.F. et al. editors. Cancer Medicine. Philadelphia: Lea and Febigger, 1138-1146; 1993.

De Groot, L.J.; Kaplan, E.L. – Second operations for "completation" of thyroidectomy in the treatment of differentiated thyroid cancer. Surgery, 110: 936-939, 1991.

Levin, K.E.; Clark, A.H.; Duh, Q.Y.; Demeure, M.; Siperstein, A.E. - Reoperative thyroid surgery.Surgery, 111: 604-609, 1992.

Rodrigues, J. - Carcinoma da tireóide. Rio de Janeiro, 1969, tese de livre docência. Faculdade de Medicina da U.F.R.J.

Cady, B.; Rossi, R.L. - An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery, 104. 947-950, 1988.

Vassilopoulou-Seilin, R.; Klein, M.J.; Smith, T.H.; Samaan, N.A.; Frankenthaier, R.A. et al. - Pulmonary metastases in children and young aduits with differentiated thyroid cancer. Cancer, 71: 1348-1552, 1993. DOI: https://doi.org/10.1002/1097-0142(19930215)71:4<1348::AID-CNCR2820710429>3.0.CO;2-3

Dadparvar, S.; Krishna, L.; Brady, L.V.; Siixofski, W.J.; Brown, S.J. et al. - The roie iodine- 131 and thailium-20 1 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer, 71: 3767-3773, 1993. DOI: https://doi.org/10.1002/1097-0142(19930601)71:11<3767::AID-CNCR2820711146>3.0.CO;2-W

Aksien, L.A.; Haidorsen, T.; Thoresen, S.O.; Glattre, E. - Survival and causes of death in thyroid cancer: A population-based study of 2479 cases from Norway. Cancer Res, 51: 1234-124 1, 1991.

Robbins, J; Merino, M.J.; Boice, J.D. Jr.; Ron, E.; Ain, K.B. et al. – Thyroid cancer: a letal endocrine neoplasm. Ann Intern Med, 115: 133-147, 1991. DOI: https://doi.org/10.7326/0003-4819-115-2-133

Casara, D.; Rubello, D.; Saladini, G.; Masarotto, G.; Favera, A.; Girelii, M.E. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables.J Nuc l Med, 34: 1626-163 1, 1993.

Emerick, G.T.; Duh, Q.Y.; Siperstein, A.E.; Burrow, G.N.; Clark, O.H. - Diagnosis, treatment and outcome of follicular thyroid carcinoma. Cancer, 72: 3287-3295, 1993. DOI: https://doi.org/10.1002/1097-0142(19931201)72:11<3287::AID-CNCR2820721126>3.0.CO;2-5

Bushnell, D.L.; Boies, M.A.; Kaufman, G.A.; Wadas, M.A.; Barnes, W.E. - Compiications, sequeia and dosimetry of iodine- 131 therapy for thyroid carcinoma. J Nuci Med 33 2214-2221, 1992.

Hancock, S.L.; Cox, R.S.; McDougall, 1.1. - Thyroid diseases after treatment of Hodgkin disease.N Engl J Med, 325: 599-605, 1991. DOI: https://doi.org/10.1056/NEJM199108293250902

Nicolau, W. - Tireotoxicose. In: Waschenberg, B.L. editor. Tratado de Endocrinologia Clínica. São Paulo: Livraria Roca, 3 30-403; 1992.

Hales, I.B.; McElduff, A.; Crummer, P.; Clifton-Bligh, P.; Deibrigde, L. et al. - Does Graves disease or thyrotoxicosis affect the prognosis of thyroid cancer? J Nucl Endocrinol Metab, 75:886-889, 1992. DOI: https://doi.org/10.1210/jcem.75.3.1517381

Smith, M.; McHenry, C.; Jarosa, H. et al. Carcinoma of the thyroid in patients with autonomous nodules. Ann Surg, 54(7): 488-492, 1988.

Croon, R.D.; thomas, C.G.; Reddick, R.L. et al. Autonomously functioning thyroid nodules in chilhood and adolescence. Surgery, 102(6):110-115, 1987.

Rosier, H.; Winpfheimer, C.; Ruchtil et al. Hyperthyroidism in patients with thyroid cancer. Nuki Med, 23(6): 293-297, 1984.

Mazzaferri, EL. - Management of a solitary thyroid noduie. N Engi J Med, 328: 553-558, 1993. DOI: https://doi.org/10.1056/NEJM199302253280807

Downloads

Published

2022-09-29

How to Cite

1.
Calegaro JUM, Calegaro NQM, Duarte LV, Araujo MRA, Miziara MD, Gomes Ênio de F, Motta LACR da, Andrade MA de. Treatment of differentiated carcinoma of thyroid gland with surgery and adjuvante Radioiodine- 131. Rev. Bras. Cancerol. [Internet]. 2022 Sep. 29 [cited 2024 May 18];42(4):209-17. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/2901

Issue

Vol. 42 No. 4 (1996): Oct./Nov./Dec.

Section

ORIGINAL ARTICLE

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)